FR
9
Projects
1
Coordinated
7
As Partner
€794,144
Total Budget
Budget Range
Min
€45,921
Average
€88,238
Max
€136,063
Role Distribution
Sector Distribution
Budget by Sector (€)
Projects (9)
P
Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
HORIZON.2.1101213916
€136,063
P
Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
Health101096362
€106,073
P
COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE
Health101103746
€99,841
P
OPTIMAL METHODS TO CHARACTERIZE ADC RESISTANCE IN SOLID TUMORS AND IDENTIFY CLINICALLY USEFUL BIOMARKERS
Health101156771
€99,415
C
Personalized Adjuvant Treatment for HR+/HER2- breast cancer FOR YOUNG patients
Health101156800
€94,986
P
Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer
Health101136953
€79,999
P
INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL
Health101104574
€71,857
P
Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors
Health101104684
€59,988
P
PRE-ACT: Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification
Health101057746
€45,921